GlassScriptPhysician profile
Vikas V Varma
NPI 1386684314
$28,967.37
in general payments reported to CMS, 2019-2025
26 companies · $6,929 in 2025
The $6,929 reported for 2025 was more than what 85% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $263 · 2021: $2,104 · 2022: $6,424 · 2023: $1,230 · 2024: $1,748 · 2025: $6,929.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,328 · Food and Beverage: $3,579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,327.57 |
| Food and Beverage | $3,579.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,804.55 | 2021-2025 | Cd Horizon Spinal System, Mazor X System, Unid_pass |
| Medtronic USA, INC. | $3,798.39 | 2019 | |
| Nuvasive, INC. | $3,641.77 | 2019-2021 | |
| Globus Medical, INC. | $3,367.87 | 2019-2025 | Excelsius Gps, Excelsiusgps Robotic Navigation System, Creo Threaded |
| Stryker Corporation | $2,748.81 | 2019-2025 | Mako |
| Medical Device Business Services, INC. | $2,706.04 | 2019-2025 | Velys |
| Alphatec Spine, INC | $1,837.58 | 2022-2025 | Invictus Open, Other - Miscellaneous, Solus Alif |
| Ecential Robotics | $1,227.36 | 2025 | |
| Depuy Synthes Sales INC. | $942.99 | 2019-2025 | Teligen, Trialtis, Fibergraft Bg Morsels |
| Painteq LLC | $597.24 | 2022 | |
| Integrity Implants INC. | $375.17 | 2021 | |
| Theragen, INC. | $150.00 | 2023 | Actastim-S |
| Spineology INC. | $144.30 | 2020 | |
| Nevro Corp. | $136.39 | 2021 | |
| Redhill Biopharma INC. | $111.68 | 2020-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $108.87 | 2023 | |
| Cerapedics INC. | $44.80 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Mdd US Operations, LLC | $42.36 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $34.07 | 2023 | Seglentis |
| Takeda Pharmaceuticals U.S.A., INC. | $26.92 | 2025 | Trintellix |
| Fidia Pharma USA INC. | $25.00 | 2021 | |
| Radius Health, INC. | $25.00 | 2021 | |
| Sanofi-Aventis U.S. LLC | $23.66 | 2020 | |
| Horizon Therapeutics Plc | $17.47 | 2020 | |
| Endo Pharmaceuticals INC. | $14.81 | 2021 | |
| Pfizer INC. | $14.27 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikas Varma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.